FDA Issues Final Guidance for Model-Informed Drug Development

The FDA has released its final guidance, "M15 General Principles for Model-Informed Drug Development," developed in collaboration with the International Council for Harmonisation. This document offers recommendations for the planning, evaluation, and documentation of evidence in drug development processes. The guidance aims to standardize understanding and assessment frameworks within the industry, potentially streamlining future drug approvals.